Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

Form SCHEDULE 13D/A Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC Jun 17, 2026 07:42PM

Form 144 Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC Jun 15, 2026 09:21PM

Form 144 Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC Jun 15, 2026 09:19PM

Form SCHEDULE 13D/A Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC Jun 17, 2025 05:30PM

Form SC 13D/A Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC May 20, 2024 04:56PM

May 17, 2024 03:08PM Form 144 Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
May 17, 2024 03:04PM Form 144 Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
Apr 4, 2024 04:40PM Form SC 13D/A Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 28, 2023 04:00PM Form SC 13D Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 27, 2023 08:31PM Form 4 Enliven Therapeutics, For: Feb 23 Filed by: ORBIMED ADVISORS LLC

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed